首页 > 最新文献

Journal of Advanced Pharmaceutical Technology & Research最新文献

英文 中文
Antioxidant, toxicity, and cytotoxicity activities from dichloromethane root extract and fraction of Rhizophora stylosa Griff. 二氯甲烷根提取物及部位的抗氧化、毒性及细胞毒活性。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-01 Epub Date: 2025-10-20 DOI: 10.4103/JAPTR.JAPTR_89_25
Nurdin Saidi, Binawati Ginting, Mustanir Yahya, Murniana Murniana, Agnia Purnama, Cantika Dwi Riski

Rhizophora stylosa Griff. roots contain bioactive metabolites and therapeutic potential. This study measured the antioxidants, toxicity and cytotoxicity from its dichloromethane extract and four derived fractions (RSD 1-4). The extracts showed strong antioxidant activity (IC50 = 7.50 ppm) and toxicity (LC50 = 31.92 ppm). Evaluation of each fraction showed that RSD 2 had the highest activity for antioxidant bioactivity with IC50 of 45.40 ppm and toxicity with LC50 value of 332.48 ppm. Cytotoxicity against MCF-7 cells showed that RSD 3 had the stronger effect, followed by RSD 2 with IC50 values of 225.50 ppm and 155.90 ppm, respectively. Statistical analysis confirmed that differences in antioxidant and toxicity activities among extract and fractions were significant (P < 0.05), whereas cytotoxic activity differences were not statistically significant. Gas chromatography-mass spectrometry analysis of RSD 2 identified stigmasta-3,5-diene, α-amyrin, and lupeol as major components and potentially responsible for the bioactivities. In summary, dichloromethane root extract of R. stylosa Griff. may serve as phytomedicines for breast cancer.

茎尖根霉。根含有生物活性代谢物和治疗潜力。本研究测定了其二氯甲烷提取物及其衍生物的抗氧化剂、毒性和细胞毒性(RSD 1-4)。提取物具有较强的抗氧化活性(IC50 = 7.50 ppm)和毒性(LC50 = 31.92 ppm)。结果表明,RSD 2的抗氧化活性最高,IC50为45.40 ppm,毒性最高,LC50为332.48 ppm。对MCF-7细胞的细胞毒作用显示,RSD 3的作用较强,RSD 2次之,IC50值分别为225.50 ppm和155.90 ppm。经统计学分析,各提取物和各组分的抗氧化活性和毒性活性差异显著(P < 0.05),而细胞毒活性差异无统计学意义。RSD - 2的气相色谱-质谱分析表明,柱头-3,5-二烯、α-amyrin和luphil是其主要成分,可能与其生物活性有关。综上所述,柱头草二氯甲烷根提取物。可以作为治疗乳腺癌的植物药。
{"title":"Antioxidant, toxicity, and cytotoxicity activities from dichloromethane root extract and fraction of <i>Rhizophora stylosa</i> Griff.","authors":"Nurdin Saidi, Binawati Ginting, Mustanir Yahya, Murniana Murniana, Agnia Purnama, Cantika Dwi Riski","doi":"10.4103/JAPTR.JAPTR_89_25","DOIUrl":"10.4103/JAPTR.JAPTR_89_25","url":null,"abstract":"<p><p><i>Rhizophora stylosa</i> Griff. roots contain bioactive metabolites and therapeutic potential. This study measured the antioxidants, toxicity and cytotoxicity from its dichloromethane extract and four derived fractions (RSD 1-4). The extracts showed strong antioxidant activity (IC<sub>50</sub> = 7.50 ppm) and toxicity (LC<sub>50</sub> = 31.92 ppm). Evaluation of each fraction showed that RSD 2 had the highest activity for antioxidant bioactivity with IC<sub>50</sub> of 45.40 ppm and toxicity with LC<sub>50</sub> value of 332.48 ppm. Cytotoxicity against MCF-7 cells showed that RSD 3 had the stronger effect, followed by RSD 2 with IC<sub>50</sub> values of 225.50 ppm and 155.90 ppm, respectively. Statistical analysis confirmed that differences in antioxidant and toxicity activities among extract and fractions were significant (<i>P</i> < 0.05), whereas cytotoxic activity differences were not statistically significant. Gas chromatography-mass spectrometry analysis of RSD 2 identified stigmasta-3,5-diene, α-amyrin, and lupeol as major components and potentially responsible for the bioactivities. In summary, dichloromethane root extract of <i>R. stylosa</i> Griff. may serve as phytomedicines for breast cancer.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 4","pages":"177-182"},"PeriodicalIF":1.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12610292/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Cytotoxicity test and the potency of polyvinyl alcohol-based Moringa oleifera nanoparticles on cancer cell death: In vitro study. 细胞毒性试验和聚乙烯醇基辣木纳米颗粒对癌细胞死亡的效力:体外研究。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_213_25

[This corrects the article on p. 80 in vol. 16, PMID: 40510893.].

[这是对第16卷第80页的文章的更正,PMID: 40510893]。
{"title":"Erratum: Cytotoxicity test and the potency of polyvinyl alcohol-based Moringa oleifera nanoparticles on cancer cell death: <i>In vitro</i> study.","authors":"","doi":"10.4103/JAPTR.JAPTR_213_25","DOIUrl":"10.4103/JAPTR.JAPTR_213_25","url":null,"abstract":"<p><p>[This corrects the article on p. 80 in vol. 16, PMID: 40510893.].</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"169"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality outcomes of extended-spectrum β-lactamase in bacteremia with carbapenems and other antibiotics: A systematic review. 用碳青霉烯类和其他抗生素治疗菌血症时广谱β-内酰胺酶的死亡率:一项系统综述。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_30_25
Mariyatul Qibtiyah, Afini Safiro, Elvin Nuzulistina, Rafi Addimaysqi, Joni Wahyuhadi, Junaidi Khotib

The study examined the mortality outcomes of extended-spectrum β-lactamase (ESBL)-producing bacteria in Enterobacteriaceae, specifically Klebsiella pneumoniae and Escherichia coli, and reviewed evidence on carbapenem-sparing regimens to avoid carbapenem use in treating ESBL infections, focusing on patients with bacteremia. This study analyzed 30-day all-cause mortality outcomes in adult patients over 18 years treated with carbapenem compared to other antibiotics for bloodstream infections caused by ESBL using Scopus, PubMed, and Sage Journal databases from 2015 to 2024, using pooled risk ratios and 95% confidence intervals for all outcomes. Eight studies found no significant differences between groups receiving carbapenems and other antibiotics. However, carbapenems were found to have a higher 30-day all-cause mortality rate than comparative antibiotics for ESBL in bacteremia. Two studies reported lower 30-day all-cause mortality rates when using carbapenems. There was no significant correlation between antibiotic use and ESBL-related mortality in bacteremia patients. Most carbapenem therapy users had a higher mortality rate than those using other antibiotics; however, the difference was not statistically significant.

该研究检查了肠杆菌科(特别是肺炎克雷伯菌和大肠杆菌)中产生广谱β-内酰胺酶(ESBL)的细菌的死亡率结果,并回顾了碳青霉烯保留方案的证据,以避免碳青霉烯在治疗ESBL感染时使用,重点是菌血症患者。本研究使用Scopus、PubMed和Sage期刊数据库,分析了2015年至2024年期间接受碳青霉烯类药物治疗的18岁以上成人患者与其他抗生素治疗ESBL血流感染的30天全因死亡率结果,使用所有结果的合并风险比和95%置信区间。8项研究发现,接受碳青霉烯类和其他抗生素治疗的两组之间没有显著差异。然而,碳青霉烯类药物在ESBL菌血症中的30天全因死亡率高于比较抗生素。两项研究报告使用碳青霉烯类药物降低了30天的全因死亡率。菌血症患者抗生素使用与esbl相关死亡率无显著相关性。大多数碳青霉烯类药物使用者的死亡率高于其他抗生素使用者;然而,差异无统计学意义。
{"title":"Mortality outcomes of extended-spectrum β-lactamase in bacteremia with carbapenems and other antibiotics: A systematic review.","authors":"Mariyatul Qibtiyah, Afini Safiro, Elvin Nuzulistina, Rafi Addimaysqi, Joni Wahyuhadi, Junaidi Khotib","doi":"10.4103/JAPTR.JAPTR_30_25","DOIUrl":"10.4103/JAPTR.JAPTR_30_25","url":null,"abstract":"<p><p>The study examined the mortality outcomes of extended-spectrum β-lactamase (ESBL)-producing bacteria in <i>Enterobacteriaceae</i>, specifically <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i>, and reviewed evidence on carbapenem-sparing regimens to avoid carbapenem use in treating ESBL infections, focusing on patients with bacteremia. This study analyzed 30-day all-cause mortality outcomes in adult patients over 18 years treated with carbapenem compared to other antibiotics for bloodstream infections caused by ESBL using Scopus, PubMed, and Sage Journal databases from 2015 to 2024, using pooled risk ratios and 95% confidence intervals for all outcomes. Eight studies found no significant differences between groups receiving carbapenems and other antibiotics. However, carbapenems were found to have a higher 30-day all-cause mortality rate than comparative antibiotics for ESBL in bacteremia. Two studies reported lower 30-day all-cause mortality rates when using carbapenems. There was no significant correlation between antibiotic use and ESBL-related mortality in bacteremia patients. Most carbapenem therapy users had a higher mortality rate than those using other antibiotics; however, the difference was not statistically significant.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"113-118"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solubility improvement of atorvastatin using deep eutectic solvents. 用深共晶溶剂改善阿托伐他汀的溶解度。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_337_24
Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, Taofik Rusdiana

Deep eutectic solvents (DESs) in pharmaceutical investigations are still largely unknown in terms of safety, environmental acceptability, and practical use. The investigation focus is primarily of attempts to improve solubility is examined using the co-crystallization approach, which follows similar principles to the production of eutectic mixtures. We will look into the eutectic mixture interaction between selected coformers (nicotinamide [NA], isonicotinamide, and citric acid as acceptors of hydrogen bond and atorvastatin calcium trihydrate [ATCH] as donors of hydrogen bond in the DES system, assisted by propylene glycol [PG]). The study found that the optimum interaction in the DES system for ATCH is using NA in PG as a carrier, with evaluation by polarization microscopy, Fourier transform infrared spectroscopy (FT-IR), and differential scanning calorimetry (DSC), verifying that the drug and the DES components have formed H-bonds. H-bond interactions had been recognized through FT-IR and DSC, revealing that the DESs with NA coformer can increase ATCH solubility, as shown in the phase diagram. The increase in solubility was fairly considerable, allowing ATCH to dissolve at high concentrations in DESs, with a solubility of 0.158 ± 0.098 mg/mL compared to 0.000597 ± 0.003 mg/mL in water. Thus, it is obtainable to conclude that among the selected coformers, the DES system with the potential for improving the solubility of ATCH is DESs with NA coformer assisted by PG.

深共晶溶剂(DESs)在药物研究方面的安全性、环境可接受性和实际应用仍然很大程度上是未知的。研究重点主要是利用共结晶方法来提高溶解度,这与生产共晶混合物的原理相似。我们将研究在DES体系中选择的共晶混合物(烟酰胺[NA]、异烟酰胺和柠檬酸为氢键受体,阿托伐他汀三水合钙[ATCH]为氢键供体,丙二醇[PG]辅助)之间的相互作用。通过极化显微镜、傅里叶变换红外光谱(FT-IR)和差示扫描量热法(DSC)的评价,验证了药物与DES组分之间形成了氢键。通过FT-IR和DSC识别了氢键相互作用,发现带有NA共构象的DESs可以增加ATCH的溶解度,如相图所示。溶解度的增加相当可观,使得ATCH在高浓度的DESs中溶解,溶解度为0.158±0.098 mg/mL,而在水中的溶解度为0.000597±0.003 mg/mL。由此可以得出结论,在所选的共形体中,具有提高ATCH溶解度潜力的DES体系是PG辅助下的NA共形DES体系。
{"title":"Solubility improvement of atorvastatin using deep eutectic solvents.","authors":"Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, Taofik Rusdiana","doi":"10.4103/JAPTR.JAPTR_337_24","DOIUrl":"10.4103/JAPTR.JAPTR_337_24","url":null,"abstract":"<p><p>Deep eutectic solvents (DESs) in pharmaceutical investigations are still largely unknown in terms of safety, environmental acceptability, and practical use. The investigation focus is primarily of attempts to improve solubility is examined using the co-crystallization approach, which follows similar principles to the production of eutectic mixtures. We will look into the eutectic mixture interaction between selected coformers (nicotinamide [NA], isonicotinamide, and citric acid as acceptors of hydrogen bond and atorvastatin calcium trihydrate [ATCH] as donors of hydrogen bond in the DES system, assisted by propylene glycol [PG]). The study found that the optimum interaction in the DES system for ATCH is using NA in PG as a carrier, with evaluation by polarization microscopy, Fourier transform infrared spectroscopy (FT-IR), and differential scanning calorimetry (DSC), verifying that the drug and the DES components have formed H-bonds. H-bond interactions had been recognized through FT-IR and DSC, revealing that the DESs with NA coformer can increase ATCH solubility, as shown in the phase diagram. The increase in solubility was fairly considerable, allowing ATCH to dissolve at high concentrations in DESs, with a solubility of 0.158 ± 0.098 mg/mL compared to 0.000597 ± 0.003 mg/mL in water. Thus, it is obtainable to conclude that among the selected coformers, the DES system with the potential for improving the solubility of ATCH is DESs with NA coformer assisted by PG.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"144-150"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spray film-forming system formulation of Mitragyna speciosa as a diabetic wound healer. 糖尿病创面治疗剂密天牛喷雾成膜系统配方研究。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_398_24
Putri Rachma Novitasari, Fatma Nuraisyah, Baso Didik Hikmawan, Islamudin Ahmad, Sitti Nur Djannah

Diabetic wounds are chronic complications in patients with diabetes mellitus characterized by an elongated proliferation period, leading to a longer wound closure time. The lack of topical remedies for diabetic wounds necessitates the development of formulations that effectively facilitate closure. Kratom (Mitragyna speciosa) leaves, containing polyphenolic compounds, have the potential to be developed into a film spray suitable for diabetic wound closure. This study aims to develop a film-spray formula of kratom leaves extracted using natural deep eutectic solvent (NADES) and to investigate its wound healing activity on type I diabetic rats. Polyphenol-rich NADES extracts were formulated with a film-forming base in concentrations of 2%, 3%, and 4% v/v. The sprays were assessed for pH, viscosity, drying time, and organoleptic properties and evaluated for their effectiveness in reducing wound diameter on streptozotocin-induced diabetic rats. All formulated sprays exhibited watery form, dark orange, and odor characteristics of kratom extract, and the stability test showed that no separation was observed. The wound healing activity evaluation revealed that the film spray containing 4% of kratom NADES extract on day 21 demonstrated significant healing effects on type I diabetic rats, including a reduction in wound diameter (83.99 ± 12.02%), a decrease in neutrophil cell count, and an increase in epithelial tissue thickness. Kratom NADES extract film-forming spray (4%) has the potential to shorten the closure time of diabetic wounds.

糖尿病创面是糖尿病患者的慢性并发症,其特点是增殖期延长,创面愈合时间延长。缺乏局部治疗糖尿病伤口需要配方的发展,有效地促进关闭。红木(Mitragyna speciosa)叶片含有多酚类化合物,有潜力发展成为适合糖尿病伤口愈合的薄膜喷雾。本研究旨在研究天然深共熔溶剂(NADES)提取的苦参叶成膜喷雾配方,并研究其对1型糖尿病大鼠的创面愈合作用。以2%、3%和4% v/v的成膜碱配制富含多酚的NADES提取物。评估喷雾的pH值、粘度、干燥时间和感官特性,并评估其对链脲佐菌素诱导的糖尿病大鼠伤口直径的减少效果。所有配制的喷雾剂均表现出苦楝提取物的水状、深橙色和气味特征,稳定性试验表明无分离现象。创面愈合活性评价显示,含4%苦参提取物的膜喷雾在第21天对1型糖尿病大鼠具有显著的愈合作用,包括创面直径减少(83.99±12.02%),中性粒细胞计数减少,上皮组织厚度增加。Kratom NADES提取物成膜喷雾剂(4%)具有缩短糖尿病创面愈合时间的潜力。
{"title":"Spray film-forming system formulation of <i>Mitragyna speciosa</i> as a diabetic wound healer.","authors":"Putri Rachma Novitasari, Fatma Nuraisyah, Baso Didik Hikmawan, Islamudin Ahmad, Sitti Nur Djannah","doi":"10.4103/JAPTR.JAPTR_398_24","DOIUrl":"10.4103/JAPTR.JAPTR_398_24","url":null,"abstract":"<p><p>Diabetic wounds are chronic complications in patients with diabetes mellitus characterized by an elongated proliferation period, leading to a longer wound closure time. The lack of topical remedies for diabetic wounds necessitates the development of formulations that effectively facilitate closure. Kratom (<i>Mitragyna speciosa</i>) leaves, containing polyphenolic compounds, have the potential to be developed into a film spray suitable for diabetic wound closure. This study aims to develop a film-spray formula of kratom leaves extracted using natural deep eutectic solvent (NADES) and to investigate its wound healing activity on type I diabetic rats. Polyphenol-rich NADES extracts were formulated with a film-forming base in concentrations of 2%, 3%, and 4% v/v. The sprays were assessed for pH, viscosity, drying time, and organoleptic properties and evaluated for their effectiveness in reducing wound diameter on streptozotocin-induced diabetic rats. All formulated sprays exhibited watery form, dark orange, and odor characteristics of kratom extract, and the stability test showed that no separation was observed. The wound healing activity evaluation revealed that the film spray containing 4% of kratom NADES extract on day 21 demonstrated significant healing effects on type I diabetic rats, including a reduction in wound diameter (83.99 ± 12.02%), a decrease in neutrophil cell count, and an increase in epithelial tissue thickness. Kratom NADES extract film-forming spray (4%) has the potential to shorten the closure time of diabetic wounds.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"119-124"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simplex lattice design for the development of arrowroot starch and sodium alginate with calcium chloride crosslinker as a capsule shell alternative. 采用单纯形点阵设计开发了以竹芋淀粉和海藻酸钠为交联剂的胶囊壳,以氯化钙为替代。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_381_24
Sabtanti Harimurti, Nabila Khaula Rahma, Dyani Primasari Sukamdi, Hari Widada, Sri Nabawiyati Nurul Makiyah, Tri Wulandari Kesetyaningsih, Muhammad Thesa Ghozali, Hari Susanti

Gelatin, commonly used for capsule shells, is mostly imported from Europe and America to Indonesia. However, Indonesia's rich biodiversity offers abundant natural alternatives like arrowroot and alginate. The need for local raw material independence in pharmaceuticals drives this research. This study aims to determine whether arrowroot starch and sodium alginate with calcium chloride as a crosslinker can replace gelatin capsule shells. This study involved five capsule shell formulas (F1-F5), with evaluations on characteristics, swelling %, disintegration time, dispersive X-ray, Fourier-transform infrared (FTIR) analysis, and simplex lattice design (SLD) method optimization, using commercial capsules (CCs) as a control. We used the one-sample t-test. F3 showed the best results in weight uniformity (0.22 ± 0.01 g), %swelling (45.84 ± 0.08%), and disintegration time (8.22 ± 0.85 min), compared to the CC, i.e., weight uniformity (0.12 ± 0.003 g), %swelling (43.26 ± 0.03%), and disintegration time (6.19 ± 1.38 min). Morphologically, F3 was the most homogeneous, resembling CC. FTIR analysis showed hydroxyl band from carboxylic group shifts indicating crosslinking, with notable changes from 1416.6 to 1386.9/cm in F3 and 1417.7-1394.0/cm in F5 after CaCl₂ addition. SLD validation was performed on three model-generated equations using experimental data. The differences between predicted and experimental results were 34.54% (weight uniformity), 3.12% (swelling), and 5.35% (disintegration time). A one-sample t-test showed no significant differences (α > 0.05). Arrowroot starch and sodium alginate with calcium chloride crosslinker can be used as an alternative to capsule shells.

通常用于制作胶囊壳的明胶主要是从欧美进口到印尼的。然而,印度尼西亚丰富的生物多样性提供了丰富的天然替代品,如竹菜和海藻酸盐。制药行业对当地原材料独立的需求推动了这项研究。本研究旨在确定以氯化钙为交联剂的竹芋淀粉和海藻酸钠是否可以替代明胶胶囊壳。本研究以商用胶囊(CCs)为对照,对5种胶囊壳配方(F1-F5)进行了特性评价、溶胀率、崩解时间、色散x射线、傅里叶变换红外(FTIR)分析和单纯形晶格设计(SLD)方法优化。我们使用了单样本t检验。F3在重量均匀性(0.22±0.01 g)、溶胀率(45.84±0.08%)和崩解时间(8.22±0.85 min)方面优于CC(0.12±0.003 g)、溶胀率(43.26±0.03%)和崩解时间(6.19±1.38 min)。FTIR分析显示,羧基上的羟基带发生了移位,表明交联,加入氯化钙后,F3的变化幅度从1416.6 ~ 1386.9/cm, F5的变化幅度从1417.7 ~ 1394.0/cm。利用实验数据对三个模型生成的方程进行了SLD验证。预测结果与实验结果的差异分别为重量均匀度34.54%、溶胀度3.12%、崩解时间5.35%。单样本t检验差异无统计学意义(α > 0.05)。以氯化钙为交联剂的竹淀粉和海藻酸钠可作为胶囊壳的替代品。
{"title":"Simplex lattice design for the development of arrowroot starch and sodium alginate with calcium chloride crosslinker as a capsule shell alternative.","authors":"Sabtanti Harimurti, Nabila Khaula Rahma, Dyani Primasari Sukamdi, Hari Widada, Sri Nabawiyati Nurul Makiyah, Tri Wulandari Kesetyaningsih, Muhammad Thesa Ghozali, Hari Susanti","doi":"10.4103/JAPTR.JAPTR_381_24","DOIUrl":"10.4103/JAPTR.JAPTR_381_24","url":null,"abstract":"<p><p>Gelatin, commonly used for capsule shells, is mostly imported from Europe and America to Indonesia. However, Indonesia's rich biodiversity offers abundant natural alternatives like arrowroot and alginate. The need for local raw material independence in pharmaceuticals drives this research. This study aims to determine whether arrowroot starch and sodium alginate with calcium chloride as a crosslinker can replace gelatin capsule shells. This study involved five capsule shell formulas (F1-F5), with evaluations on characteristics, swelling %, disintegration time, dispersive X-ray, Fourier-transform infrared (FTIR) analysis, and simplex lattice design (SLD) method optimization, using commercial capsules (CCs) as a control. We used the one-sample <i>t</i>-test. F3 showed the best results in weight uniformity (0.22 ± 0.01 g), %swelling (45.84 ± 0.08%), and disintegration time (8.22 ± 0.85 min), compared to the CC, i.e., weight uniformity (0.12 ± 0.003 g), %swelling (43.26 ± 0.03%), and disintegration time (6.19 ± 1.38 min). Morphologically, F3 was the most homogeneous, resembling CC. FTIR analysis showed hydroxyl band from carboxylic group shifts indicating crosslinking, with notable changes from 1416.6 to 1386.9/cm in F3 and 1417.7-1394.0/cm in F5 after CaCl₂ addition. SLD validation was performed on three model-generated equations using experimental data. The differences between predicted and experimental results were 34.54% (weight uniformity), 3.12% (swelling), and 5.35% (disintegration time). A one-sample <i>t</i>-test showed no significant differences (α > 0.05). Arrowroot starch and sodium alginate with calcium chloride crosslinker can be used as an alternative to capsule shells.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"125-132"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2-((3-(chloromethyl) benzoyl) oxy) benzoic acid suppresses NF-κB expression in the kidneys and lungs of LPS-Induced BALB/C mice. 2-((3-(氯甲基)苯甲酰)氧)苯甲酸抑制lps诱导的BALB/C小鼠肾脏和肺部NF-κ b的表达。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_61_25
Kuncoro Foe, Philipus Karel, Martha Ervina, Yudy Tjahjono, Hendy Wijaya, Bernadette Dian Novita Dewi, Claritta Angelina Wiyanto Putri, Fransiskus Regis Partana, Michelle Angelina, Sianty Dewi, Senny Yesery Esar, Wuryanto Hadinugroho, Hevi Wihadmadyatami, Caroline

Sepsis, a life-threatening systemic inflammatory condition, is a leading cause of mortality worldwide. Its pathophysiology involves the activation of nuclear factor kappa beta (NF-κB), which promotes the release of proinflammatory cytokines. Acetylsalicylic acid (ASA), a widely used nonsteroidal anti-inflammatory drug, inhibits NF-κB but poses risks of peptic ulcer disease and nephrotoxicity. This study evaluates the efficacy of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid (3-CH2Cl), a novel salicylate derivative, in reducing NF-κB expression in the kidneys and lungs of lipopolysaccharide (LPS)-induced septic BALB/C mice. Mice were divided into four groups: untreated, LPS only, LPS + ASA (60 mg/kg BW), and LPS + 3-CH2Cl (60 mg/kg BW). NF-κB expression was assessed via immunohistochemistry. LPS significantly increased NF-κB expression in both renal and pulmonary tissues compared to controls (P < 0.0001). While ASA treatment reduced NF-κB levels (P < 0.0001), 3-CH2Cl demonstrated superior suppression in the renal cortex, renal medulla, and alveolar regions (P < 0.05). In addition, 3-CH2Cl alleviated hypothermia in septic mice, comparable to ASA. Given its enhanced anti-inflammatory efficacy and reduced gastrointestinal risk, 3-CH2Cl presents a promising alternative to ASA for sepsis-related inflammation management. Further studies are warranted to explore its clinical applications.

败血症是一种危及生命的全身性炎症,是世界范围内死亡的主要原因。其病理生理机制涉及核因子κ b (NF-κB)的激活,促进促炎细胞因子的释放。乙酰水杨酸(ASA)是一种广泛使用的非甾体抗炎药,可抑制NF-κB,但具有消化性溃疡疾病和肾毒性的风险。本研究评价了新型水杨酸衍生物2-((3-(氯甲基)苯甲酰)氧基)苯甲酸(3- ch2cl)降低脂多糖(LPS)诱导的脓毒性BALB/C小鼠肾脏和肺部NF-κ b表达的效果。小鼠分为未处理组、LPS组、LPS + ASA组(60 mg/kg BW)和LPS + 3-CH2Cl组(60 mg/kg BW)。免疫组化法检测NF-κB表达。与对照组相比,LPS显著增加肾组织和肺组织中NF-κB的表达(P < 0.0001)。ASA降低了NF-κB水平(P < 0.0001), 3-CH2Cl在肾皮质、肾髓质和肺泡区表现出更强的抑制作用(P < 0.05)。此外,3-CH2Cl可减轻脓毒症小鼠的低温,与ASA相当。鉴于其增强的抗炎功效和降低胃肠道风险,3-CH2Cl在脓毒症相关炎症的治疗中有望取代ASA。值得进一步研究其临床应用价值。
{"title":"2-((3-(chloromethyl) benzoyl) oxy) benzoic acid suppresses NF-κB expression in the kidneys and lungs of LPS-Induced BALB/C mice.","authors":"Kuncoro Foe, Philipus Karel, Martha Ervina, Yudy Tjahjono, Hendy Wijaya, Bernadette Dian Novita Dewi, Claritta Angelina Wiyanto Putri, Fransiskus Regis Partana, Michelle Angelina, Sianty Dewi, Senny Yesery Esar, Wuryanto Hadinugroho, Hevi Wihadmadyatami, Caroline","doi":"10.4103/JAPTR.JAPTR_61_25","DOIUrl":"10.4103/JAPTR.JAPTR_61_25","url":null,"abstract":"<p><p>Sepsis, a life-threatening systemic inflammatory condition, is a leading cause of mortality worldwide. Its pathophysiology involves the activation of nuclear factor kappa beta (NF-κB), which promotes the release of proinflammatory cytokines. Acetylsalicylic acid (ASA), a widely used nonsteroidal anti-inflammatory drug, inhibits NF-κB but poses risks of peptic ulcer disease and nephrotoxicity. This study evaluates the efficacy of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid (3-CH<sub>2</sub>Cl), a novel salicylate derivative, in reducing NF-κB expression in the kidneys and lungs of lipopolysaccharide (LPS)-induced septic BALB/C mice. Mice were divided into four groups: untreated, LPS only, LPS + ASA (60 mg/kg BW), and LPS + 3-CH<sub>2</sub>Cl (60 mg/kg BW). NF-κB expression was assessed via immunohistochemistry. LPS significantly increased NF-κB expression in both renal and pulmonary tissues compared to controls (<i>P</i> < 0.0001). While ASA treatment reduced NF-κB levels (<i>P</i> < 0.0001), 3-CH<sub>2</sub>Cl demonstrated superior suppression in the renal cortex, renal medulla, and alveolar regions (<i>P</i> < 0.05). In addition, 3-CH<sub>2</sub>Cl alleviated hypothermia in septic mice, comparable to ASA. Given its enhanced anti-inflammatory efficacy and reduced gastrointestinal risk, 3-CH<sub>2</sub>Cl presents a promising alternative to ASA for sepsis-related inflammation management. Further studies are warranted to explore its clinical applications.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"163-168"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a BALB/c mice model for blue light retinal damage. 蓝光视网膜损伤BALB/c小鼠模型的建立。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_32_25
Arief Wildan, Banundari Rachmawati, Arief Sjamsulaksan Kartasasmita, Fifin Luthfia Rahmi, Maharani, Hermawan Istiadi, Anditta Syifarahmah, Irwan Nurdiansyah, Noviana Fitri Wulandari, Shofia Salsabilah

Blue light exposure can damage the retina, resulting in retinal atrophy and significant vision loss. Currently, no efficient animal models can observe retinal damage caused by blue light within a defined timeframe. Creating a BALB/c mouse model for blue light-induced retinal damage is expected to enhance research focused on the prevention and treatment of age-related macular degeneration. This study explores the potential effect of blue light exposure on the BALB/c mice model by analysing apoptosis and retinal degeneration. Anatomical Pathology Laboratory of Diponegoro University and The Integrated Research and Testing Laboratory of Gadjah Mada University. This study design was a posttest-only control group design. Ten five-week-old BALB/c mice were divided into two groups. The exposure group received 10,000 lux of blue light in the special cage for 2 weeks, 3 h daily. Caspase-3 expression was assessed through polymerase chain reaction testing, and retinal thickness was analyzed using hematoxylin and eosin staining. We used the Shapiro-Wilk test to evaluate data normality. Parametric t-tests and nonparametric Mann-Whitney tests were applied to compare groups, with P < 0.05 considered significant. The average whole retinal thickness of the exposed group was 152.812 ± 20.919 µm, while the control group was 214.948 ± 53.284 µm (P = 0.04). The average caspase-3 expression in the exposed group was 19.03 ± 8.57 µm, while the control group was 5.78 ± 2.63 µm (P = 0.011). This approach, utilizing animal models for blue light exposure, can be employed to learn about retinal damage caused by blue light.

蓝光照射会损害视网膜,导致视网膜萎缩和严重的视力丧失。目前,没有有效的动物模型可以在规定的时间内观察到蓝光引起的视网膜损伤。建立蓝光诱导视网膜损伤的BALB/c小鼠模型有望加强对年龄相关性黄斑变性预防和治疗的研究。本研究通过分析细胞凋亡和视网膜变性,探讨蓝光照射对BALB/c小鼠模型的潜在影响。Diponegoro大学解剖病理学实验室和Gadjah Mada大学综合研究与测试实验室。本研究设计为纯后测对照组设计。10只5周龄BALB/c小鼠分为两组。暴露组在专用笼中接受10000勒克斯蓝光照射,连续2周,每天3小时。采用聚合酶链反应检测Caspase-3表达,苏木精和伊红染色检测视网膜厚度。我们使用Shapiro-Wilk检验来评估数据的正态性。比较组采用参数t检验和非参数Mann-Whitney检验,以P < 0.05为差异有统计学意义。暴露组视网膜全层平均厚度为152.812±20.919µm,对照组为214.948±53.284µm (P = 0.04)。暴露组caspase-3平均表达量为19.03±8.57µm,对照组为5.78±2.63µm (P = 0.011)。这种方法利用蓝光暴露的动物模型,可以用来了解蓝光引起的视网膜损伤。
{"title":"Development of a BALB/c mice model for blue light retinal damage.","authors":"Arief Wildan, Banundari Rachmawati, Arief Sjamsulaksan Kartasasmita, Fifin Luthfia Rahmi, Maharani, Hermawan Istiadi, Anditta Syifarahmah, Irwan Nurdiansyah, Noviana Fitri Wulandari, Shofia Salsabilah","doi":"10.4103/JAPTR.JAPTR_32_25","DOIUrl":"10.4103/JAPTR.JAPTR_32_25","url":null,"abstract":"<p><p>Blue light exposure can damage the retina, resulting in retinal atrophy and significant vision loss. Currently, no efficient animal models can observe retinal damage caused by blue light within a defined timeframe. Creating a BALB/c mouse model for blue light-induced retinal damage is expected to enhance research focused on the prevention and treatment of age-related macular degeneration. This study explores the potential effect of blue light exposure on the BALB/c mice model by analysing apoptosis and retinal degeneration. Anatomical Pathology Laboratory of Diponegoro University and The Integrated Research and Testing Laboratory of Gadjah Mada University. This study design was a posttest-only control group design. Ten five-week-old BALB/c mice were divided into two groups. The exposure group received 10,000 lux of blue light in the special cage for 2 weeks, 3 h daily. Caspase-3 expression was assessed through polymerase chain reaction testing, and retinal thickness was analyzed using hematoxylin and eosin staining. We used the Shapiro-Wilk test to evaluate data normality. Parametric <i>t</i>-tests and nonparametric Mann-Whitney tests were applied to compare groups, with <i>P</i> < 0.05 considered significant. The average whole retinal thickness of the exposed group was 152.812 ± 20.919 µm, while the control group was 214.948 ± 53.284 µm (<i>P</i> = 0.04). The average caspase-3 expression in the exposed group was 19.03 ± 8.57 µm, while the control group was 5.78 ± 2.63 µm (<i>P</i> = 0.011). This approach, utilizing animal models for blue light exposure, can be employed to learn about retinal damage caused by blue light.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"139-143"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of mouthwash exposure to stainless steel temporary anchorage device on cytotoxicity and inflammation levels of BHK-21 cells. 漱口水暴露于不锈钢临时锚定装置对BHK-21细胞毒性和炎症水平的影响。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_256_24
Kartissa Pangesti, Haru Setyo Anggani, Endang Winiati Bachtiar

Stainless steel temporary anchorage device (SS TAD) has toxic risk due to the content that may be released when exposed to the oral environment, and the mouthwash being used. This research aims to analyze the cytotoxicity of SS TAD and measure the inflammation level in cells after exposure to three types of mouthwash. SS TADs (n = 28) were divided into four groups (n = 7 per group) and immersed in the following mouthwash solutions for 90 days. The resulting eluates were then applied to BHK-21 fibroblast cell cultures and incubated for 24 h. Matrix metalloproteinase-8 (MMP-8) levels in the supernatants on days 1 and 7 were measured using enzyme-linked immunosorbent assay MMP-8 kit. BHK-21 fibroblast cells showed significant differences in reactivity (P < 0.05) after exposure to SS TAD eluate in povidone-iodine (PVP-I) and chitosan mouthwash, compared to control groups without SS TAD. Viability test revealed significant differences (P < 0.05) after exposure to SS TAD eluate in PVP-I mouthwash compared to PVP-I alone. The reactivity of BHK-21 fibroblast cells exposed to fluoride and distilled water was not significantly different (P > 0.05) from control groups without SS TAD. The viability of BHK-21 fibroblast cells exposed to fluoride and distilled water did not differ significantly from control groups without SS TAD. MMP-8 levels differed significantly between SS TAD eluate groups (P < 0.05) on day 1 and day 7, with day 7 levels significantly higher than day 1. The most recommended mouthwash is chitosan for TAD SS users rather than fluoride and PVP-I.

不锈钢临时锚固器(SS TAD)暴露于口腔环境和使用漱口水时可能释放的内容物具有毒性风险。本研究旨在分析SS TAD的细胞毒性,并测量三种漱口水对细胞的炎症水平。SS TADs (n = 28)分为4组(每组n = 7),分别浸泡于以下漱口水溶液中90 d。将洗脱液应用于BHK-21成纤维细胞培养,孵育24 h。采用酶联免疫吸附法MMP-8试剂盒检测第1天和第7天上清液中基质金属蛋白酶-8 (Matrix metalloproteinase-8, MMP-8)水平。聚维酮碘(PVP-I)和壳聚糖漱口水中SS - TAD洗脱液后,BHK-21成纤维细胞的反应性与不含SS - TAD的对照组相比有显著差异(P < 0.05)。活性测试显示,与单独暴露于PVP-I漱口水中的SS TAD洗脱液相比,暴露于PVP-I漱口水后的存活率差异显著(P < 0.05)。氟和蒸馏水对BHK-21成纤维细胞的反应性与不含SS TAD的对照组无显著差异(P < 0.05)。暴露于氟和蒸馏水的BHK-21成纤维细胞的活力与不含SS TAD的对照组无显著差异。第1天和第7天,SS - TAD洗脱组间MMP-8水平差异显著(P < 0.05),第7天水平显著高于第1天。对于TAD SS使用者来说,最推荐的漱口水是壳聚糖,而不是氟化物和PVP-I。
{"title":"Effects of mouthwash exposure to stainless steel temporary anchorage device on cytotoxicity and inflammation levels of BHK-21 cells.","authors":"Kartissa Pangesti, Haru Setyo Anggani, Endang Winiati Bachtiar","doi":"10.4103/JAPTR.JAPTR_256_24","DOIUrl":"10.4103/JAPTR.JAPTR_256_24","url":null,"abstract":"<p><p>Stainless steel temporary anchorage device (SS TAD) has toxic risk due to the content that may be released when exposed to the oral environment, and the mouthwash being used. This research aims to analyze the cytotoxicity of SS TAD and measure the inflammation level in cells after exposure to three types of mouthwash. SS TADs (<i>n</i> = 28) were divided into four groups (<i>n</i> = 7 per group) and immersed in the following mouthwash solutions for 90 days. The resulting eluates were then applied to BHK-21 fibroblast cell cultures and incubated for 24 h. Matrix metalloproteinase-8 (MMP-8) levels in the supernatants on days 1 and 7 were measured using enzyme-linked immunosorbent assay MMP-8 kit. BHK-21 fibroblast cells showed significant differences in reactivity (<i>P</i> < 0.05) after exposure to SS TAD eluate in povidone-iodine (PVP-I) and chitosan mouthwash, compared to control groups without SS TAD. Viability test revealed significant differences (<i>P</i> < 0.05) after exposure to SS TAD eluate in PVP-I mouthwash compared to PVP-I alone. The reactivity of BHK-21 fibroblast cells exposed to fluoride and distilled water was not significantly different (<i>P</i> > 0.05) from control groups without SS TAD. The viability of BHK-21 fibroblast cells exposed to fluoride and distilled water did not differ significantly from control groups without SS TAD. MMP-8 levels differed significantly between SS TAD eluate groups (<i>P</i> < 0.05) on day 1 and day 7, with day 7 levels significantly higher than day 1. The most recommended mouthwash is chitosan for TAD SS users rather than fluoride and PVP-I.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"151-155"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro release and in vivo study of quercetin-loaded alginate-kappa carrageenan pulmospheres. 槲皮素-海藻酸-卡拉胶肺球体外释放及体内研究。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-07-01 Epub Date: 2025-08-09 DOI: 10.4103/JAPTR.JAPTR_376_24
Dewi Melani Hariyadi, Lubby Razan Fawwaz, Abdul Fattah, Noorma Rosita, Tutiek Purwanti, Tristiana Erawati

Some antituberculosis drugs were reported to have adverse effects. The study investigates the use of quercetin pulmospheres as an alternative to traditional antituberculosis drugs. Formulated with alginate and kappa carrageenan as F1, F2, and F3 (1:1, 1:2, and 1:3), the pulmospheres were observed for the release and deposition in rat lungs. Results show a sustained release of 50.47% ±0.43%-58.37% ±0.57% in 10 h above minimum inhibitory concentration (MIC) against Mycobacterium tuberculosis and provided Higuchi kinetics model. Pulmospheres delivered quercetin to the lungs and showed a deposition with high concentrations. The slowest rate was occurred in pulmospheres with polymer ratio of 1:2. Formula F2 showed the most optimal results with the lowest rhodamine B concentration of 11.934 ± 2.751-12.364 ± 0.070 µg/g and 6.987 ± 1.931-8.685 ± 2.672 µg/g for left and right lung, respectively, which produced same MIC compare to F1 and F3. The study suggests further evaluation of effective doses for antituberculosis.

据报道,一些抗结核药物有不良反应。这项研究调查了槲皮素肺球作为传统抗结核药物的替代品的使用。以海藻酸盐和卡拉胶为F1、F2和F3(1:1、1:2和1:3)配制,观察肺球在大鼠肺中的释放和沉积情况。结果表明,在最低抑菌浓度(MIC)以上10 h缓释为50.47%±0.43% ~ 58.37%±0.57%,并建立了Higuchi动力学模型。肺球将槲皮素输送到肺部,并呈高浓度沉积。聚合物比为1:2时,肺球的反应速率最慢。公式F2效果最佳,左肺和右肺罗丹明B浓度最低,分别为11.934±2.751-12.364±0.070µg/g和6.987±1.931-8.685±2.672µg/g, MIC与F1和F3相同。这项研究建议进一步评估抗结核药物的有效剂量。
{"title":"<i>In vitro</i> release and <i>in vivo</i> study of quercetin-loaded alginate-kappa carrageenan pulmospheres.","authors":"Dewi Melani Hariyadi, Lubby Razan Fawwaz, Abdul Fattah, Noorma Rosita, Tutiek Purwanti, Tristiana Erawati","doi":"10.4103/JAPTR.JAPTR_376_24","DOIUrl":"10.4103/JAPTR.JAPTR_376_24","url":null,"abstract":"<p><p>Some antituberculosis drugs were reported to have adverse effects. The study investigates the use of quercetin pulmospheres as an alternative to traditional antituberculosis drugs. Formulated with alginate and kappa carrageenan as F1, F2, and F3 (1:1, 1:2, and 1:3), the pulmospheres were observed for the release and deposition in rat lungs. Results show a sustained release of 50.47% ±0.43%-58.37% ±0.57% in 10 h above minimum inhibitory concentration (MIC) against <i>Mycobacterium tuberculosis</i> and provided Higuchi kinetics model. Pulmospheres delivered quercetin to the lungs and showed a deposition with high concentrations. The slowest rate was occurred in pulmospheres with polymer ratio of 1:2. Formula F2 showed the most optimal results with the lowest rhodamine B concentration of 11.934 ± 2.751-12.364 ± 0.070 µg/g and 6.987 ± 1.931-8.685 ± 2.672 µg/g for left and right lung, respectively, which produced same MIC compare to F1 and F3. The study suggests further evaluation of effective doses for antituberculosis.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 3","pages":"133-138"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Advanced Pharmaceutical Technology & Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1